HLN vs. CL, EL, KVUE, ELF, COTY, NTCOY, IPAR, ODD, EPC, and OLPX
Should you be buying Haleon stock or one of its competitors? The main competitors of Haleon include Colgate-Palmolive (CL), Estée Lauder Companies (EL), Kenvue (KVUE), e.l.f. Beauty (ELF), Coty (COTY), Natura &Co (NTCOY), Inter Parfums (IPAR), Oddity Tech (ODD), Edgewell Personal Care (EPC), and Olaplex (OLPX). These companies are all part of the "toilet preparations" industry.
Colgate-Palmolive (NYSE:CL) and Haleon (NYSE:HLN) are both large-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, community ranking, valuation and profitability.
Colgate-Palmolive has a beta of 0.4, indicating that its share price is 60% less volatile than the S&P 500. Comparatively, Haleon has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500.
Colgate-Palmolive has higher revenue and earnings than Haleon. Haleon is trading at a lower price-to-earnings ratio than Colgate-Palmolive, indicating that it is currently the more affordable of the two stocks.
80.4% of Colgate-Palmolive shares are owned by institutional investors. Comparatively, 6.7% of Haleon shares are owned by institutional investors. 0.4% of Colgate-Palmolive shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
In the previous week, Colgate-Palmolive had 10 more articles in the media than Haleon. MarketBeat recorded 11 mentions for Colgate-Palmolive and 1 mentions for Haleon. Haleon's average media sentiment score of 1.03 beat Colgate-Palmolive's score of 0.36 indicating that Colgate-Palmolive is being referred to more favorably in the media.
Colgate-Palmolive received 518 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 50.29% of users gave Colgate-Palmolive an outperform vote while only 39.29% of users gave Haleon an outperform vote.
Colgate-Palmolive presently has a consensus target price of $92.35, suggesting a potential downside of 0.45%. Given Haleon's stronger consensus rating and higher probable upside, analysts plainly believe Colgate-Palmolive is more favorable than Haleon.
Colgate-Palmolive pays an annual dividend of $2.00 per share and has a dividend yield of 2.2%. Haleon pays an annual dividend of $0.21 per share and has a dividend yield of 2.5%. Colgate-Palmolive pays out 63.3% of its earnings in the form of a dividend. Haleon pays out 70.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Colgate-Palmolive has raised its dividend for 62 consecutive years and Haleon has raised its dividend for 1 consecutive years.
Colgate-Palmolive has a net margin of 13.22% compared to Colgate-Palmolive's net margin of 9.68%. Haleon's return on equity of 485.40% beat Colgate-Palmolive's return on equity.
Summary
Colgate-Palmolive beats Haleon on 20 of the 21 factors compared between the two stocks.
Get Haleon News Delivered to You Automatically
Sign up to receive the latest news and ratings for HLN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
